文献速递脑血管病神经重症与神经感染

弗雷明汉心脏研究1948-2016年脑出血发病率与危险因素评估

Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016.
PubMed 文献 · JAMA Neurol · 2020-01-01

未调整发病率随时间上升,但年龄调整后第2至第3期略有下降;75岁及以上人群发病率持续上升,第3期达176例/10万人年。抗凝药使用从第2期4.4%增至第3期13.9%。收缩压和舒张压升高及他汀使用与深部脑出血相关,收缩压升高和载脂蛋白E ε4纯合子与脑叶脑出血相关。

要点

  • 75岁及以上人群脑出血发病率持续上升,第3期达176例/10万人年。
  • 高血压是深部和脑叶脑出血共同的可治疗危险因素。

核心结论

  • 最年长人群脑出血发病率上升,高血压是深部和脑叶脑出血共同的可治疗危险因素,他汀使用与深部脑出血风险相关。

研究设计与样本

  • 129例参与者发生首发自发性脑出血,排除后99例分为两个嵌套病例对照样本:脑叶脑出血55例和深部脑出血44例,按年龄和性别1:4匹配396名无卒中事件对照。

主要发现

  • 未调整发病率随时间上升,但年龄调整发病率在第2期(1987-1999)至第3期(2000-2016)略有下降。
  • 年龄分层分析显示75岁及以上患者脑出血发病率持续上升,第3期达176例/10万人年。
  • 抗凝药使用从第2期4.4%增至第3期13.9%,同期增加3倍。

临床怎么用

  • 对高龄人群应加强脑出血风险评估与血压管理。
  • 使用他汀时需关注深部脑出血风险,尤其在高龄或血压控制不佳者中。
  • 载脂蛋白E ε4纯合子携带者合并高血压时脑叶脑出血风险升高,可作为风险分层参考。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Intracerebral hemorrhage (ICH) has the highest mortality of all stroke types and is the most serious complication of anticoagulation. Data regarding trends in ICH incidence and location-specific risk factors on the population level are conflicting. OBJECTIVE: To assess long-term population-based trends in the incidence of ICH, examine incidence rates stratified by deep and lobar locations, and characterize location-specific risk factors. DESIGN, SETTING, AND PARTICIPANTS: This longitudinal prospective community-based cohort study comprised 10 333 original participants (n = 5209; age range, 28-62 years) and offspring participants (n = 5124; age range, 5-70 years) from the Framingham Heart Study who were followed up from January 1, 1948, to December 31, 2016. Original and offspring patient cohorts were confirmed to have experienced a spontaneous ICH event through imaging or pathologic testing. A total of 129 participants were identified with a primary incident of ICH. After exclusions, the remaining 99 patients were divided into 2 nested case-control samples, which were created by stratifying the first incident of ICH by brain region (lobar ICH or deep ICH), with 55 patients included in the lobar ICH sample and 44 patients included in the deep ICH sample. Patients were matched by age and sex (1:4 ratio) with 396 individuals without any stroke event (the control group). No participant in the patient samples was excluded or approached for consent, as their initial consent to participate in the Framingham Heart Study included consent to follow-up of cardiovascular outcomes. Data were analyzed in October 2019. MAIN OUTCOMES AND MEASURES: The unadjusted and age-adjusted ICH incidence rates, assessed in 3 periods (period 1, from 1948-1986; period 2, from 1987-1999; and period 3, from 2000-2016) to study incidence trends. Nested case-control samples were used to examine baseline risk factors and medication exposures with the incidence of ICH events located in the lobar and deep brain regions within the 10 years before participants experienced a stroke event. RESULTS: Of 10 333 original and offspring participants in the Framingham Heart Study, 129 patients (72 women [55.8%]; mean [SD] age, 77 [11] years) experienced a primary ICH incident during a follow-up period of 68 years (301 282 person-years), with an incidence rate of 43 cases per 100 000 person-years. The unadjusted incidence rate increased over time, but the age-adjusted incidence rate decreased slightly between periods 2 and 3. An age-stratified analysis indicated a continued increase in ICH incidence among patients 75 years and older, reaching 176 cases per 100 000 person-years in period 3. A concurrent 3-fold increase in the use of anticoagulant medications was observed, from 4.4% in period 2 to 13.9% in period 3. The incidence rate increased substantially with age for both lobar and deep ICH. Higher systolic and diastolic blood pressure and statin medication use (odds ratio [OR], 4.07; 95% CI, 1.16-14.21; P = .03) were associated with the incidence of deep ICH. Higher systolic blood pressure and apolipoprotein E ε4 allele homozygosity (OR, 3.66; 95% CI, 1.28-10.43; P = .02) were associated with the incidence of lobar ICH. CONCLUSIONS AND RELEVANCE: This study found that the incidence of ICH increased in the oldest patients. Hypertension is a treatable risk factor for both deep and lobar ICH, while the use of statin medications is associated with the risk of a deep ICH event.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Lioutas VA, Beiser AS, Aparicio HJ, et al. Assessment of Incidence and Risk Factors of Intracerebral Hemorrhage Among Participants in the Framingham Heart Study Between 1948 and 2016. JAMA Neurol. 2020. PMID: 32511690. doi:10.1001/jamaneurol.2020.1512

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。